These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6741250)

  • 21. Breast cancer trials--a new initiative.
    Br Med J (Clin Res Ed); 1981 Feb; 282(6263):562-4. PubMed ID: 6780125
    [No Abstract]   [Full Text] [Related]  

  • 22. [Survival kinetics of breast cancer patients undergoing combined chemotherapy for recurrences and metastases].
    Korman DB; Maslova IA; Borisov AI
    Vopr Onkol; 1982; 28(8):14-9. PubMed ID: 7113064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
    Rabinovich MG; Leone BA; Landó O
    Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359
    [No Abstract]   [Full Text] [Related]  

  • 24. [Carcinoembryonic antigen in assessing treatment effectiveness in lung cancer].
    Barbolin VI; Gabuniia RI; Abramov VF
    Med Radiol (Mosk); 1980 Oct; 25(10):12-6. PubMed ID: 7421445
    [No Abstract]   [Full Text] [Related]  

  • 25. The cost effectiveness of tamoxifen in the prevention of breast cancer.
    Noe LL; Becker RV; Gradishar WJ; Gore M; Trotter JP
    Am J Manag Care; 1999 Jun; 5(6 Suppl):S389-406. PubMed ID: 10538851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K; Lippman M
    Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.
    O'Byrne KJ; Dobbs N; Propper DJ; Braybrooke JP; Koukourakis MI; Mitchell K; Woodhull J; Talbot DC; Schally AV; Harris AL
    Br J Cancer; 1999 Mar; 79(9-10):1413-8. PubMed ID: 10188884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weight loss during therapy for advanced breast cancer.
    Rowland-Payne CM; Abbott M; Jones JM; Powles TJ; Coombes RC
    Clin Oncol; 1982 Mar; 8(1):33-8. PubMed ID: 7075043
    [No Abstract]   [Full Text] [Related]  

  • 29. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
    Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
    Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy of breast cancer.
    Bonadonna G
    Br J Hosp Med; 1980 Jan; 23(1):40, 45, 48 passim. PubMed ID: 6986934
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cytostatic therapy of metastatic breast cancer].
    Mussa A; Dogliotti L; Musumeci SV; Linfanti CV; Alabiso O; Festa V; Giugno G; Sandrucci S; Benedetto G
    Minerva Chir; 1980 Aug 15-31; 35(15-16):1195-225. PubMed ID: 7005745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer trials--a new initiative.
    Br Med J; 1980 Dec; 281(6254):1565-6. PubMed ID: 7437881
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chemotherapy of carcinoma of the breast].
    Periti P; Mazzei T
    Minerva Ginecol; 1982 Nov; 34(11):959-62. PubMed ID: 7155423
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
    Chang YC; Falkson G; Tormey DC; Crowley J
    Cancer Clin Trials; 1981; 4(4):377-80. PubMed ID: 6797746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC; Paridaens R
    Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients.
    Loven D; Rakowsky E; Stein JA; Geier A; Lunenfeld B
    Isr J Med Sci; 1981; 17(9-10):960-4. PubMed ID: 7309485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
    Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
    Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
    Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
    Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
    [No Abstract]   [Full Text] [Related]  

  • 39. Trastuzumab: new indication. Metastatic breast cancer, in combination with docetaxel: promising, but more evaluation is needed.
    Prescrire Int; 2006 Feb; 15(81):3-5. PubMed ID: 16548094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision-making factors in the adjuvant treatment of operable breast cancer.
    Ahmann FR
    Ariz Med; 1982 Jun; 39(6):383-4, 389. PubMed ID: 7115121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.